Resistance is not futile: RAS inhibition resensitizes AML

subclonal levels already in the initial stages. 5,8,9 However, subclone detection with targeted panels relies primarily on SNVs and indels and will always be constrained by the necessarily restricted design of the panel.

Authors

Cailin Collins (ORCID: https://orcid.org/0000-0001-5025-0065)
Ravindra Majeti

Institutions

Stratford University (US)
Stanford University (US)

Publication Details

Journal: Blood
Published: 2026-01-15
DOI: https://doi.org/10.1182/blood.2025031932
Primary Topic: Acute Myeloid Leukemia Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Resistance is not futile: RAS inhibition resensitizes AML

Cailin Collins, Ravindra Majeti

Jan 15, 2026

Blood

Acute Myeloid Leukemia Research

article

Resistance is not futile: RAS inhibition resensitizes AML

Cailin Collins, Ravindra Majeti

January 15, 2026article en

Abstract

BloodVol. 147(3)

Stratford University (US), Stanford University (US)

Zero hunger

Openalex Percentile: Top 89%

Acute Myeloid Leukemia Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Resistance is not futile: RAS inhibition resensitizes AML — Cailin Collins, Ravindra Majeti · Blood (2026) | TGRS Research Map | TGRS